These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 921830)

  • 21. [Clinical experience with levamisole treatment of patients with systemic lupus erythematosus (author's transl)].
    Scherak O; Smolen J; Kolarz G; Kojer M; Menzel J
    Wien Klin Wochenschr; 1979 Nov; 91(22):758-62. PubMed ID: 160142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Levamisole].
    Esposito G; De Maddi F
    Pediatria (Napoli); 1980 Jun; 88(2):295-301. PubMed ID: 7017586
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of levamisole in the adjuvant therapy of rheumatoid arthritis and systemic lupus erythematosus].
    Gandzha IM; Sakharchuk VM; Lysenko GI; Mironova KA; Galetskaia TM
    Vrach Delo; 1981 Feb; (2):16-8. PubMed ID: 7222600
    [No Abstract]   [Full Text] [Related]  

  • 24. Alteration of lymphocyte function in NZB/NZW mice. IV. Response to levamisole.
    Hahn BH; Knotts LL
    Arthritis Rheum; 1979 Mar; 22(3):236-42. PubMed ID: 33681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of levamisol in rheumatic diseases].
    Bunchuk NV; Tsvetkova ES; Rachkov SM; Sigidin IaA
    Ter Arkh; 1977; 49(11):74-9. PubMed ID: 605405
    [No Abstract]   [Full Text] [Related]  

  • 26. [The present-day treatment of systemic lupus erythematosus].
    Karchova TIu; Demin AA
    Revmatologiia (Mosk); 1989; (4):59-66. PubMed ID: 2700239
    [No Abstract]   [Full Text] [Related]  

  • 27. Levamisole-induced hypersensitivity.
    Christiansen FT; Ng KC; Zilko PJ; Dawkins RL
    Lancet; 1977 May; 1(8021):1112. PubMed ID: 68217
    [No Abstract]   [Full Text] [Related]  

  • 28. Circulating immune complexes and monocyte Fc function in autoimmune diseases.
    Kávai M; Lukács K; Sonkoly I; Páloczi K; Szegedi G
    Ann Rheum Dis; 1979 Feb; 38(1):79-83. PubMed ID: 434951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of rheumatoid arthritis by levamisole. First results].
    Sany J; Morlock G; Clot J; Serre H
    Rev Rhum Mal Osteoartic; 1977 Mar; 44(3):143-53. PubMed ID: 322247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lymphocyte transformation during immunosuppressive therapy of lupus erythematosus visceralis].
    Heine KM; Klatt R; Stobbe H; Apostoloff E; Jendrusch C
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:152-4. PubMed ID: 5402572
    [No Abstract]   [Full Text] [Related]  

  • 31. Hereditary C2 deficiency associated with cutaneous lupus erythematosus: clinical, laboratory, and genetic studies.
    Levy SB; Pinnell SR; Meadows L; Snyderman R; Ward FE
    Arch Dermatol; 1979 Jan; 115(1):57-61. PubMed ID: 760659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical review of the effect of levamisole in rheumatic diseases other than rheumatoid arthritis.
    Rosenthal M
    J Rheumatol Suppl; 1978; 4():97-100. PubMed ID: 366146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depressed in vitro B-lymphocyte differentiation in systemic lupus erythematosus.
    Bobrove AM; Miller P
    Arthritis Rheum; 1977; 20(7):1326-33. PubMed ID: 303104
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of vitamin A treatment on the immune reactivity of patients with systemic lupus erythematosus.
    Vien CV; González-Cabello R; Bodó I; Gergely P
    J Clin Lab Immunol; 1988 May; 26(1):33-5. PubMed ID: 3184159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The in vitro effect of levamisole on histamine inhibited E-rosette forming T-lymphocyte subpopulation in patients affected by disseminated erythematosus lupus.
    Pozsonyi T; Jakab L; Fehér J; Cseh K
    Allergol Immunopathol (Madr); 1982; 10(6):435-9. PubMed ID: 6220589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ribavirin: efficacy in the treatment of murine autoimmune disease.
    Klassen LW; Budman DR; Williams GW; Steinberg AD; Gerber NL
    Science; 1977 Feb; 195(4280):787-9. PubMed ID: 299957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic trials with levamisole and other agents in NZB/W mice.
    Russell AS
    J Rheumatol; 1976 Dec; 3(4):380-3. PubMed ID: 1088166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of treatment with encorton and cytostatics on cellular immunity in patients with systemic lupus erythematosus].
    Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz T; Wierzchowska E
    Reumatologia; 1982; 20(3-4):137-42. PubMed ID: 7187069
    [No Abstract]   [Full Text] [Related]  

  • 39. The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients.
    Michalevicz R; Many A; Ramot B; Trainin N
    Clin Exp Immunol; 1978 Jan; 31(1):111-5. PubMed ID: 639342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocyte sensitivity assay as a marker for glucocorticoid resistance in lupus: report of two sisters with systemic lupus erythematosus.
    Fajardo-Hermosillo LD; Rodríguez-Navedo Y; Nadal AJ; Vilá LM
    Lupus; 2014; 23(1):88-92. PubMed ID: 24285097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.